Buprenorphine Treatment: Advanced Practice Nurses Add Capacity
Joanne Spetz, Laurie Hailer, Caryl Gay, Matthew Tierney, Laura A. Schmidt, Bethany J. Phoenix, Susan A. Chapman
Abstract
During the COVID-19 pandemic, there was slower growth in the number of new waivers authorizing clinicians to provide buprenorphine treatment for opioid use disorder. However, treatment capacity grew at a stable rate as a result of already authorized clinicians obtaining waivers for larger patient panels. Advanced practice nurses accounted for the largest portion of capacity growth during the pandemic.
Topics & Concepts
BuprenorphineOpioid use disorderPandemicCoronavirus disease 2019 (COVID-19)MedicineOpioidMedical emergencyFamily medicineBusinessInternal medicineInfectious disease (medical specialty)ReceptorDiseaseOpioid Use Disorder TreatmentPoisoning and overdose treatmentsCardiac Arrest and Resuscitation